[HIV infection]

Same author

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program <sup>a</sup>.

Open forum infectious diseases·2026

Same author

Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial.

The lancet. HIV·2026

Same author

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Antiviral therapy·2026

Same author

Factors associated with loss to follow-up among people living with HIV in France.

AIDS (London, England)·2026

Same author

Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV.

Diabetes & metabolism·2026

Same journal

[Prolonged fever].

La Revue du praticien·2026

Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026

Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026

Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026

Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026

Same journal

[Patient education in heart failure].

La Revue du praticien·2026

Related Experiment Videos

[HIV infection]

Related Concept Videos

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program <sup>a</sup>.

Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial.

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Factors associated with loss to follow-up among people living with HIV in France.

Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters.

Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV.

[Prolonged fever].

[Lower gastrointestinal bleeding].

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

[A history of child abuse intervention in the West].

[Agranulocytose médicamenteuse].

[Patient education in heart failure].

Related Experiment Videos

[HIV infection]

Related Concept Videos

Related Articles

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program <sup>a</sup>.

Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial.

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Factors associated with loss to follow-up among people living with HIV in France.

Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters.

Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV.

[Prolonged fever].

[Lower gastrointestinal bleeding].

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

[A history of child abuse intervention in the West].

[Agranulocytose médicamenteuse].

[Patient education in heart failure].